Location History:
- Beiseförth, DE (2017)
- Aachen, DE (2017)
Company Filing History:
Years Active: 2017
Title: The Innovations of Robert Frank-Foltyn
Introduction
Robert Frank-Foltyn is a notable inventor based in Munich, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that interact with vanilloid receptors. With a total of two patents to his name, his work has implications for pain management and other medical conditions.
Latest Patents
Frank-Foltyn's latest patents include "Substituted oxazole- and thiazole-based carboxamide and urea derivatives as vanilloid receptor ligands II." This invention focuses on oxazole and thiazole-based carboxamide and urea derivatives, which serve as vanilloid receptor ligands. The patent also covers pharmaceutical compositions containing these compounds, aimed at treating and preventing pain and various diseases. Another significant patent is for "Substituted phenylureas and phenylamides as vanilloid receptor ligands." This patent details the processes for preparing these compounds, their pharmaceutical compositions, and their applications in drug formulation.
Career Highlights
Throughout his career, Robert Frank-Foltyn has worked with prominent companies in the pharmaceutical industry. Notable among these are Medifron Dbt Inc. and Grünenthal GmbH. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Frank-Foltyn has collaborated with several professionals in his field, including Gregor Bahrenberg and Bernhard Lesch. These collaborations have likely enhanced his research and development efforts, leading to successful patent applications.
Conclusion
Robert Frank-Foltyn's contributions to pharmaceutical innovations demonstrate his commitment to advancing medical science. His patents reflect a deep understanding of the complexities of pain management and the potential for new therapeutic solutions.